Invests in
Sectors:
Locations:
Min Investment:
$1,000,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- HM
- YS
- HE
- TT
- Uo
- Uo
- MA
Lists including Nishant
Work Experience
VP, Head of Transactions
2018
New Rhein is an operationally-oriented life sciences investment fund that applies a private equity model to biotech/medtech investing. At the core of New Rhein's strategy is a commitment to actively manage the value creation process. This involves taking substantial stakes in a select number of companies to enable focus on successful product development and commercialization, while mitigating science-based risk. New Rhein's team is comprised of former senior executives from renowned pharmaceutical companies, who bring industry-specific expertise to each deal.
2023
Member Board of Directors
2023
Pulmonary Arterial Hypertension
2022
Investor
2022
Neuromodulation for Migraine
Board Observer
2023
Metabolic / Obesity Medicine
2020
Board Observer
2020
Benign Prostatic Hyperplasia
2019
Board Observer
2019
Nerve Repair
2020 - 2023
Board Observer
2020 - 2023
Manufacturer of injectable drug products (CDMO / CMO)
2017 - 2018
MBA Associate
2017 - 2018
2017 - 2017
MBA Associate
2017 - 2017
2016 - 2017
Board Observer
2016 - 2017
Minimally Invasive Mechanical Circulatory Support